Literature DB >> 2535928

Nonpalpable in situ ductal carcinoma of the breast. Predictors of multicentricity and microinvasion and implications for treatment.

G F Schwartz1, A S Patchefsky, S D Finklestein, S H Sohn, A Prestipino, S A Feig, J S Singer.   

Abstract

Fifty breasts with nonpalpable ductal carcinoma in situ (DCIS) were examined for the presence of microinvasion, multicentricity, and number of involved ducts to see if the biopsy specimen could have predicted the findings in the remainder of the breast. When DCIS was an incidental finding, fewer ducts were involved and no evidence of either microinvasion or multicentricity was found. Solid and cribriform DCIS were rarely multicentric or microinvasive; micropapillary DCIS was often multicentric, rarely microinvasive; comedocarcinoma was more likely to be both microinvasive and multicentric. Ductal carcinoma in situ as an incidental finding may be treated by excision alone; papillary and micropapillary DCIS are best treated by therapy aimed at the entire breast, although axillary dissection may not be required. Therapy for comedocarcinomas should include the entire breast and the axillary nodes.

Entities:  

Mesh:

Year:  1989        PMID: 2535928     DOI: 10.1001/archsurg.1989.01410010035007

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  8 in total

1.  A Case of Ductal Carcinoma In Situ (DCIS:noncomedo type)Detected by Ultrasonography: Demonstration of Occult Multiple Foci.

Authors: 
Journal:  Breast Cancer       Date:  1996-06-28       Impact factor: 4.239

2.  Impact of the presence and quantity of ductal carcinoma in situ component on the outcome of invasive breast cancer.

Authors:  Carla Cedolini; Serena Bertozzi; Ambrogio P Londero; Luca Seriau; Michela Andretta; Diane Agakiza; Sandro Fongione; Alessandro Uzzau; Andrea Risaliti
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

Review 3.  Low-risk DCIS. What is it? Observe or excise?

Authors:  Sarah E Pinder; Alastair M Thompson; Jelle Wesserling
Journal:  Virchows Arch       Date:  2021-08-27       Impact factor: 4.535

4.  Incidence, characteristics, and management of recently diagnosed, microscopically invasive breast cancer by receptor status: Iowa SEER 2000 to 2013.

Authors:  Alexandra Thomas; Ronald J Weigel; Charles F Lynch; Philip M Spanheimer; Elizabeth K Breitbach; Mary C Schroeder
Journal:  Am J Surg       Date:  2016-09-02       Impact factor: 2.565

Review 5.  Management of in situ and minimally invasive breast carcinoma.

Authors:  E R Frykberg; K I Bland
Journal:  World J Surg       Date:  1994 Jan-Feb       Impact factor: 3.352

6.  Proposal for Creating a Guideline for Cancer Registration of Microinvasive Tumors of the Breast and Ovary (II).

Authors:  Jin Hee Sohn; Gyungyub Gong; Kyu Rae Kim; Chang Suk Kang; Youn Soo Lee; Jin Man Kim; Woo Hee Jung; Kwang Sun Suh
Journal:  Korean J Pathol       Date:  2012-06-22

7.  Evaluation of resection margins in breast conservation therapy: the pathology perspective-past, present, and future.

Authors:  Rajyasree Emmadi; Elizabeth L Wiley
Journal:  Int J Surg Oncol       Date:  2012-11-19

8.  Is adjuvant chemotherapy necessary for patients with microinvasive breast cancer after surgery?

Authors:  Hai-Fei Niu; Li-Juan Wei; Jin-Pu Yu; Zhen Lian; Jing Zhao; Zi-Zheng Wu; Jun-Tian Liu
Journal:  Cancer Biol Med       Date:  2016-03       Impact factor: 4.248

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.